These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
185 related articles for article (PubMed ID: 7824094)
1. The metabolization of carbamazepine to CBZ-10,11-epoxide in children from the newborn age to adolescence. Korinthenberg R; Haug C; Hannak D Neuropediatrics; 1994 Aug; 25(4):214-6. PubMed ID: 7824094 [TBL] [Abstract][Full Text] [Related]
2. Carbamazepine and its epoxide: an open study of efficacy and side effects after carbamazepine dose increment in refractory partial epilepsy. Semah F; Gimenez F; Longer E; Laplane D; Thuillier A; Baulac M Ther Drug Monit; 1994 Dec; 16(6):537-40. PubMed ID: 7878690 [TBL] [Abstract][Full Text] [Related]
3. Response to carbamazepine in children with newly diagnosed partial onset epilepsy. Holland KD; Glauser TA Neurology; 2007 Aug; 69(6):596-9. PubMed ID: 17679679 [TBL] [Abstract][Full Text] [Related]
4. Developmental and therapeutic pharmacology of antiepileptic drugs. Miura H Epilepsia; 2000; 41 Suppl 9():2-6. PubMed ID: 11156504 [TBL] [Abstract][Full Text] [Related]
5. The effect of chronic carbamazepine, valproic acid and phenytoin medication on the periodontal condition of epileptic children and adolescents. Galas-Zgorzalewicz B; Borysewicz-Lewicka M; Zgorzalewicz M; Borowicz-Andrzejewska E Funct Neurol; 1996; 11(4):187-93. PubMed ID: 8934150 [TBL] [Abstract][Full Text] [Related]
6. Effects of add-on melatonin administration on antioxidant enzymes in children with epilepsy taking carbamazepine monotherapy: a randomized, double-blind, placebo-controlled trial. Gupta M; Gupta YK; Agarwal S; Aneja S; Kalaivani M; Kohli K Epilepsia; 2004 Dec; 45(12):1636-9. PubMed ID: 15571523 [TBL] [Abstract][Full Text] [Related]
7. Carbamazepine and its epoxide: relation of plasma levels to toxicity and seizure control. Theodore WH; Narang PK; Holmes MD; Reeves P; Nice FJ Ann Neurol; 1989 Feb; 25(2):194-6. PubMed ID: 2919868 [TBL] [Abstract][Full Text] [Related]
8. The 24 hour variation of salivary carbamazepine and carbamazepine-10,11-epoxide concentrations in children with epilepsy. Bäckman E; Dahlström G; Eeg-Olofsson O; Bertler A Pediatr Neurol; 1987; 3(6):327-30. PubMed ID: 3149473 [TBL] [Abstract][Full Text] [Related]
9. [Monotherapy with carbamazepine in childhood epilepsies]. Dulac O; Bouguerra L; Rey E; de Lauture D; Arthuis M Arch Fr Pediatr; 1983 May; 40(5):415-9. PubMed ID: 6411042 [TBL] [Abstract][Full Text] [Related]
10. Carbamazepine and carbamazepine-10,11- epoxide during pregnancy and postnatal period in epileptic mother and their nursed infants: pharmacokinetics and clinical effects. Kuhnz W; Jäger-Roman E; Rating D; Deichl A; Kunze J; Helge H; Nau H Pediatr Pharmacol (New York); 1983; 3(3-4):199-208. PubMed ID: 6677873 [TBL] [Abstract][Full Text] [Related]
11. Comparison of the cognitive effects of tiagabine and carbamazepine as monotherapy in newly diagnosed adult patients with partial epilepsy: pooled analysis of two long-term, randomized, follow-up studies. Aikiä M; Jutila L; Salmenperä T; Mervaala E; Kälviäinen R Epilepsia; 2006 Jul; 47(7):1121-7. PubMed ID: 16886974 [TBL] [Abstract][Full Text] [Related]
12. The pharmacology of chewable versus regular carbamazepine in chronically treated children with epilepsy. Camfield P; Hwang P; Camfield C; Fraser A; Soldin S; al-Quadah AK Can J Neurol Sci; 1992 May; 19(2):204-7. PubMed ID: 1623447 [TBL] [Abstract][Full Text] [Related]
13. Valproic acid-carbamazepine interaction: is valproic acid a selective inhibitor of epoxide hydrolase? Svinarov DA; Pippenger CE Ther Drug Monit; 1995 Jun; 17(3):217-20. PubMed ID: 7624916 [TBL] [Abstract][Full Text] [Related]
14. Population pharmacokinetics of steady-state carbamazepine in Egyptian epilepsy patients. El Desoky ES; Sabarinath SN; Hamdi MM; Bewernitz M; Derendorf H J Clin Pharm Ther; 2012 Jun; 37(3):352-5. PubMed ID: 21883329 [TBL] [Abstract][Full Text] [Related]
15. Influence of carbamazepine-10,11-epoxide on the serum level of valproic acid in epileptic patients on combined treatment with carbamazepine and valproic acid. Minkova GD; Getova DP Folia Med (Plovdiv); 2000; 42(3):16-9. PubMed ID: 11347330 [TBL] [Abstract][Full Text] [Related]
16. Diurnal variation of carbamazepine and carbamazepine-10,11-epoxide in plasma and saliva in children with epilepsy: a comparison between conventional and slow-release formulations. Eeg-Olofsson O; Nilsson HL; Tonnby B; Arvidsson J; Grahn PA; Gylje H; Larsson C; Norén L J Child Neurol; 1990 Apr; 5(2):159-65. PubMed ID: 2111837 [TBL] [Abstract][Full Text] [Related]
17. Carbamazepine coadministration with fluoxetine or fluvoxamine. Spina E; Avenoso A; Pollicino AM; Caputi AP; Fazio A; Pisani F Ther Drug Monit; 1993 Jun; 15(3):247-50. PubMed ID: 8333006 [TBL] [Abstract][Full Text] [Related]
18. Relationships between carbamazepine-diol, carbamazepine-epoxide, and carbamazepine total and free steady-state concentrations in epileptic patients: the influence of age, sex, and comedication. Svinarov DA; Pippenger CE Ther Drug Monit; 1996 Dec; 18(6):660-5. PubMed ID: 8946662 [TBL] [Abstract][Full Text] [Related]
19. Factors influencing serum levels of carbamazepine and carbamazepine-10,11-epoxide in children. Altafullah I; Talwar D; Loewenson R; Olson K; Lockman LA Epilepsy Res; 1989; 4(1):72-80. PubMed ID: 2753022 [TBL] [Abstract][Full Text] [Related]
20. Oxcarbazepine-induced hyponatremia and the regulation of serum sodium after replacing carbamazepine with oxcarbazepine in children. Holtmann M; Krause M; Opp J; Tokarzewski M; Korn-Merker E; Boenigk HE Neuropediatrics; 2002 Dec; 33(6):298-300. PubMed ID: 12571784 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]